News
The objective of this investigation was to examine treatment persistence with glatiramer acetate (GA) relative to available disease-modifying therapies (DMT) for multiple sclerosis (MS ...
Early Treatment Of Multiple Sclerosis; Gd+: Gadolinium-enhancing; IM: Intramuscular; NA: Not applicable; PreCISe: Effect of Glatiramer Acetate Treatment in Delaying Conversion to Clinically ...
18 months after it opened an investigation into Teva to see if it illegally blocked generic versions of its big-selling multiple sclerosis ... Copaxone (glatiramer acetate) patent expired in ...
Multiple sclerosis is a progressive condition where the brain and the spinal cord get affected due to damage to the myelin sheath. This further causes a lot of neurological symptoms, such as ...
Presenting Author: Dr. John Foley – Rocky Mountain Multiple Sclerosis, Salt Lake City, Utah Following the presentations, the data presented will be available on the Publications page ...
cladribine Mavenclad 10mg tabs Give 3.5mg/kg cumulative dose divided into 2 yearly treatment courses (1.75mg/kg per treatment course). Each cycle: give 1–2 tabs once daily over 4–5 consecutive ...
World Multiple Sclerosis Day is observed every year on May 30. According to the World Health Organisation (WHO), it is estimated that over 1.8 million people have multiple sclerosis (MS ...
Among 46,000 MS patients living in temperate zones, more severe disease was seen in those who lived above 40° latitude, reported Tomas Kalincik, MD, PhD, of the University of Melbourne, Australia ...
Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative ...
William Lindsey, MD, director of the division of multiple sclerosis and neuroimmunology at the University of Texas Health Science Center at Houston. “It involves interactions between diet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results